Azasan, Imuran Side Effects May Increase Risk of Skin Cancer: Study

Irvin Jackson

Add Your Comments

Users of the immunosuppressants Azasan and Imuran may face an increased risk of developing skin cancer, according to the findings of a new study. 

Researchers with the University of Dundee in the U.K. published a study in the medical journal Nature Communications on September 10, which indicates a strong association between azathioprine, the active ingredient in the two drugs, and cutaneous squamous cell carcinoma (cSCC), a common form of skin cancer.

Azasan and Imuran are used to treat rhematoid arthritis, Crohn’s disease, inflammatory bowel disease and other immune system-related ailments. First developed in the late 1950s, it was designed to prevent rejection following organ transplant surgeries until the late 1970s.

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

Previous research has linked side effects of Azasan, Imuran and other azathioprine drugs to increased photosensitivity to type A ultraviolet (UVA) light. Researchers examined 40 primary cSCC tumors and conducted in-depth DNA sampling and genetic testing. The study found a genetic mutation signature that correlates with chronic exposure to Azasan and Imuran.

Researchers said that the drugs leave a “molecular fingerprint” on skin cancers, which, tied with the increased sensitivity that can make a patient more vulnerable to skin cancer, suggests a very strong association between the drug and the risk of cSCC.

More than 1 million new cases of cutaneous squamous cell carcinoma are diagnosed in the United States every year. Immunosuppressed individuals, such as those who have received organ transplants, are more than 100 times more likely to be diagnosed with cSCC than their peers, the researchers noted.

The skin cancer is responsible for about one-quarter of all skin cancer-related deaths in the United States, with mortality rates rivaling melanoma in some parts of the country, the researchers noted.

“We recommend all physicians give appropriate advice on UVA avoidance including year-round sun protection for their patients on azathioprine,” Professor Charlotte Proby said in a University of Dundee press release. “It is important that sun protection, skin surveillance and early diagnosis/lesion removal are part of the routine management of patients on azathioprine.”

Researchers indicated that the findings may be used to identify potential ways to manage and treat cSCC in the future.

Irvin Jackson
Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Tags: Arthritis, Azasan, Cancer, crohn's disease, Imuran, Inflammatory Bowel Disease (IBD), Skin Cancer

More Lawsuit Stories

5 Comments

Tom
Has anyone tried and/or won a lawsuit against the maker of Imuran for skin cancer?
Sara
My husband was on Imuran for 30 plus years and was not warned about CA for many of them. He had 100’s if not 1000’s of skin cancer removed. Neck dissection and radiation for SCC in lymph node. He had major scarring and disfigurements on his face from this pill and died from SCC 2020 after suffering for many many years and horrific pain right up to his death
Chez
I too used Azathioprine for 10 yrs and have had 6 plus Squamous Cell Carcinonas & possible 3 more, also 50 plus precancerous in the last year. Stopped taking Aza 18 months ago.
Julie
I have 4 removed so far and now I’m told the biopsies done last week on 4 more. Three have to be removed. The worst one was on my nose and I had to have plastic surgery. I almost lost the right side of my nose.
Chad
I have had 100+ skin cancers removed, I was on Imuran 28+ years. I have major scarring and disfigurements on my face from this toxic pill.

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Nevro Stimulator Lawsuit MDL Request Opposed by Manufacturer
The JPML has been asked to reject a petition by plaintiffs seeking to consolidate all federal Nevro spinal cord stimulator lawsuits before one federal judge, claiming the injuries and claims are too different from plaintiff to plaintiff.
Gulf War Veteran Parkinson’s Disease Lawsuits Investigated Over Pesticide Use During Operations Desert Shield and Desert Storm
Lawyers are investigating Parkinson’s disease lawsuits for Gulf War veterans potentially exposed to the pesticide chlorpyrifos during Operations Desert Shield and Desert Storm.
Nearly 4,000 Bard PowerPort Lawsuits Now Filed Amid Upcoming Bellwether Trials
C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.